Important Notices

Grifols Therapeutics LLC issued a voluntary withdrawal of two lots of Gamunex-C® (immune globulin injection [human], 10%) on Sept. 30, 2025, following a rise in reported hypersensitivity reactions associated with the affected vials.

On Aug. 27, 2025, Unichem Pharmaceuticals issued a recall for one lot of cyclobenzaprine hydrochloride 10mg tablets

On Aug. 26, 2025, B. Braun recalled Sterile Water for Injection and Sodium Chloride 0.9% Irrigation Solution due to the chance of fluid leaking from the port site.

On Aug. 11, 2025, Pfizer initiated a recall of Octagam® Immune Globulin Intravenous (Human) 10% Liquid Preparation due to the potential for damaged bottles during transport.

On Aug. 20, 2025, B. Braun issued a recall notification for two injectable products, Sodium Chloride 0.9% E3 Injection (12 x 1000 mL) and Lactated Ringer’s Injection (12 x 1000 mL).

On Aug. 13, 2025, Celltrion USA initiated a recall of one lot of Steqeyma® (ustekinumab-stba) 90 mg/mL injection due to incorrect assembly and release into the market.

On Aug. 8, 2025, Grifols Therapeutics LLC withdrew two lots of Gamunex-C® (immune globulin injection [human], 10% caprylate/chromatography purified) 20G vials to the consumer level

On July 11, 2025, Nostrum Laboratories, Inc. issued a nationwide voluntary recall of all lots for sucralfate 1g tablets.

On June 17, 2025, B. Braun Medical Inc. issued a recall for 0.9% (Sodium Chloride) NACL INJ USP 500mL due to potential fluid leakage from small pinholes in the IV bags.

On May 12, 2025, Dexcom issued an Urgent Medical Device Correction for Dexcom G6 and G7 receivers.